Track Group earnings release, August 14, 2026
August 14, 2026
James Berg
Chief Financial Officer jim.berg@trackgrp.com
Track Group Reports 3rd Quarter Fiscal 2026 Financial Results
Key Third Quarter Data Points
Key Third Quarter Strategic Accomplishments
-1-
NAPERVILLE, ILLINOIS – Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its third fiscal quarter ended June 30, 2026. “During the third quarter we accomplished a number of mission critical objectives that lay the groundwork for improving our underlying profitability and ability to provide value to our customers,” said Derek Cassell, CEO of Track Group. “Strong demand in key markets reinforces our leadership in the GPS electronic monitoring space. We are seeing strong demand for our new device and expanded tertiary products and services that are starting to translate into contract wins and expansions. While the above-mentioned timing uncertainty with a large, expected order with a long-standing customer in the middle east is frustrating, the foundation we are building and steps we are successfully taking to permanently lower our cost structure are bearing fruit. We are excited about the near-term future of the business. We continue to grow our underlying business and improve the value and offerings we are able to provide to our government partners. Revenue growth in our U.S. business, which accounts for 78% of our total revenue, was 4% in the quarter. Given the fact that we had some significant headwinds with our largest customer given a regulatory transition which is effectively complete, we feel very good about this number. We remain focused on building on this momentum, executing on recent contract wins, capitalizing on our robust pipeline opportunities, and continuing to find ways to generate value for our customers and shareholders.”
Business Outlook
Barring unforeseen circumstances, we still expect material savings to be fully incorporated into results on a run-rate basis by or near the end of fiscal 2026. These savings, which are expected to be reflected through ongoing expense reductions, are also expected to be accompanied by material decreases in ongoing capital expenditures.
While the timing of the above-mentioned delayed order given turmoil in the middle east is uncertain, we have an increasingly attractive opportunity set that should enable us to accelerate topline growth in addition to sustainable cost improvements on a go forward basis in the near future.
We expect year over year growth in revenue and underlying profitability for fiscal 2026, and for this to continue into fiscal 2027.
About Track Group, Inc.
Track Group designs, manufactures, and markets location tracking devices; as well as develops and sells a variety of related software, services, and accessories, networking solutions, and monitoring applications. The Company's products and services are designed to empower professionals in security, law enforcement, corrections, and rehabilitation organizations worldwide with single-sourced offender management solutions that integrate reliable intervention technologies to support re-socialization and monitoring initiatives.
The Company currently trades under the ticker symbol "TRCK" on the OTCQB exchange. For more information, visit www.trackgrp.com.
Financial statements
Income Statement
Three Months Ended — (Unaudited)
| Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Nine Months Ended – June 30, – 2026 | Nine Months Ended – June 30, – 2025 | ||
|---|---|---|---|---|---|
| Revenue: | Monitoring and other related services | 8,507,111 | 8,071,416 | 25,581,618 | 24,380,699 |
| Revenue: | Product sales and other | 578,225 | 1,020,026 | 1,565,341 | 1,731,392 |
| Revenue: | Total revenue | 9,085,336 | 9,091,442 | 27,146,959 | 26,112,091 |
| Cost of revenue: | Monitoring, products and other related services | 3,917,964 | 3,765,700 | 11,704,905 | 10,789,484 |
| Cost of revenue: | Depreciation & amortization included in cost of revenue | 931,653 | 734,301 | 2,447,493 | 2,192,857 |
| Cost of revenue: | Total cost of revenue | 4,849,617 | 4,500,001 | 14,152,398 | 12,982,341 |
| Cost of revenue: | Gross profit | 4,235,719 | 4,591,441 | 12,994,561 | 13,129,750 |
| Operating expense: | General & administrative | 2,232,515 | 2,078,417 | 6,706,694 | 6,636,680 |
| Operating expense: | Selling & marketing | 870,500 | 858,789 | 2,739,434 | 2,724,721 |
| Operating expense: | Research & development | 651,205 | 675,861 | 2,044,659 | 2,095,901 |
| Operating expense: | Depreciation & amortization | 231,650 | 227,568 | 687,723 | 682,506 |
| Operating expense: | (Gain) loss on sale/dissolution of subsidiary | -630,472 | 66,483 | ||
| Operating expense: | Total operating expense | 3,985,870 | 3,840,635 | 11,548,038 | 12,206,291 |
| Operating expense: | Operating income (loss) | 249,849 | 750,806 | 1,446,523 | 923,459 |
| Other income (expense): | Interest income | 1,077 | |||
| Other income (expense): | Interest expense, net | -786,003 | -568,536 | -2,026,740 | -1,703,339 |
| Other income (expense): | Currency exchange rate gain (loss) | -656,128 | 1,253,726 | -742,055 | -210,708 |
| Other income (expense): | Gain on troubled debt restructuring | 23,464,004 | 23,464,004 | ||
| Other income (expense): | Warrant liability issuance costs | -22,539 | -22,539 | ||
| Other income (expense): | Revaluation of warrant liability | 205,031 | 205,031 | ||
| Other income (expense): | Total other income (expense) | 22,204,365 | 685,190 | 20,878,778 | -1,914,047 |
| Other income (expense): | Income (loss) before income taxes | 22,454,214 | 1,435,996 | 22,325,301 | -990,588 |
| Other income (expense): | Income tax expense | 11,193 | 1,716 | 79,009 | 103,097 |
| Other income (expense): | Net income (loss) attributable to common shareholders | 22,443,021 | 1,434,280 | 22,246,292 | -1,093,685 |
| Other income (expense): | Release of cumulative translation adjustment for sale of subsidiary | -582,883 | 1,390,913 | ||
| Other income (expense): | Equity adjustment for sale of subsidiary | 571,518 | |||
| Other income (expense): | Foreign currency translation adjustments | 480,720 | -526,580 | 582,821 | 159,480 |
| Other income (expense): | Comprehensive income (loss) | 22,923,741 | 907,700 | 22,246,230 | 1,028,226 |
| Net income (loss) per share – basic: | Net income (loss) per share | 0.69 | 0.12 | 1.19 | -0.09 |
| Net income (loss) per share – basic: | Weighted average shares outstanding | 32,342,689 | 11,863,758 | 18,690,068 | 11,863,758 |
| Net income (loss) per share – diluted: | Net income (loss) per share | 0.68 | 0.12 | 1.18 | -0.09 |
| Net income (loss) per share – diluted: | Weighted average shares outstanding | 32,845,437 | 11,863,758 | 18,857,650 | 11,863,758 |
Income Statement
Three Months Ended June 30, — (amounts in thousands, except share and per share data)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Nine Months Ended June 30, – 2026 | Nine Months Ended June 30, – 2025 | ||
|---|---|---|---|---|---|
| Non-GAAP Adjusted EBITDA | Net Income (loss) attributable to common shareholders | 22,443 | 1,434 | 22,246 | -1,094 |
| Non-GAAP Adjusted EBITDA | Interest expense, net | 786 | 569 | 2,026 | 1,703 |
| Non-GAAP Adjusted EBITDA | Depreciation and amortization | 1,163 | 962 | 3,135 | 2,875 |
| Non-GAAP Adjusted EBITDA | Income taxes (1) | 11 | 2 | 79 | 103 |
| Non-GAAP Adjusted EBITDA | Foreign exchange (gain)/loss | 656 | -1,254 | 742 | 211 |
| Non-GAAP Adjusted EBITDA | Loss on sale of subsidiary | -630 | 66 | ||
| Non-GAAP Adjusted EBITDA | Gain on troubled debt restructuring | -23,464 | -23,464 | ||
| Non-GAAP Adjusted EBITDA | Other charges, net (2) | -124 | 45 | 267 | |
| Non-GAAP Adjusted EBITDA | 1,471 | 1,713 | 4,179 | 4,131 | |
| Non-GAAP Adjusted EBITDA | Non-GAAP Adjusted EBITDA, percent of revenue | 16.2% | 18.8 | 15.3% | 15.8% |
Balance Sheet
CONDENSED CONSOLIDATED BALANCE SHEETS
| (Unaudited) – June 30, – 2026 | September 30, – 2025 | ||
|---|---|---|---|
| Current assets: | Cash | 8,388,589 | 4,098,114 |
| Current assets: | Accounts receivable, net of allowance for credit losses of $876,645 and $596,059, respectively | 4,657,001 | 6,455,910 |
| Current assets: | Prepaid expense and deposits | 401,241 | 353,319 |
| Current assets: | Inventory, net of reserves of $45,899 and $61,535, respectively | 610,004 | 473,464 |
| Current assets: | Total current assets | 14,056,835 | 11,380,807 |
| Current assets: | Property and equipment, net of accumulated depreciation of $320,909 and $294,873, respectively | 546,130 | 497,889 |
| Current assets: | Monitoring equipment, net of accumulated depreciation of $6,627,928 and $5,896,304, respectively | 4,184,933 | 5,104,603 |
| Current assets: | Intangible assets, net of accumulated amortization of $23,199,268 and $21,616,041, respectively | 14,263,992 | 13,958,773 |
| Current assets: | Goodwill | 8,310,012 | 8,299,941 |
| Current assets: | Other assets, net | 1,522,988 | 1,061,507 |
| Current assets: | Total assets | 42,884,890 | 40,303,520 |
| Current liabilities: | Accounts payable | 5,395,137 | 3,709,653 |
| Current liabilities: | Accrued liabilities | 1,844,294 | 4,886,603 |
| Current liabilities: | Total current liabilities | 7,239,431 | 8,596,256 |
| Current liabilities: | Long-term debt, net of current portion | 17,582,535 | 42,720,944 |
| Current liabilities: | Long-term liabilities | 1,117,236 | 529,265 |
| Current liabilities: | Warrant liability | 550,237 |
Cash Flow
Nine Months Ended June 30, — (Unaudited)
| Nine Months Ended June 30, – 2026 | Nine Months Ended June 30, – 2025 | ||
|---|---|---|---|
| Cash flows provided by operating activities: | Net income (loss) | 22,246,292 | -1,093,685 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation and amortization | 3,135,216 | 2,875,363 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Credit losses | 270,925 | 354,661 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Sales allowance | 10,000 | -60,000 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Allowance for obsolete inventory | -15,636 | 4,513 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Deferred taxes | 2 | 16,484 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Loss on monitoring equipment included in cost of revenue | 200,740 | 268,217 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Gain on troubled debt restructuring | -23,464,004 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | Amortization of debt issuance costs | 131,964 | 61,891 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Interest added to loan payable | 90,514 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | Foreign currency exchange (gain) loss | 742,055 | 210,708 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Right of use assets/liabilities | 5,496 | 5,390 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Loss on disposal of assets | 397 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | (Gain) loss on sale/dissolution of subsidiary | -630,472 | 66,483 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Revaluation of warrant liability | -205,031 | |
| Change in assets and liabilities: | Accounts receivable, net | 1,517,983 | -1,831,773 |
| Change in assets and liabilities: | Inventories, net | -120,904 | -627,485 |
| Change in assets and liabilities: | Current assets held for sale | 719,201 | |
| Change in assets and liabilities: | Prepaid expense, deposits and other assets | -278,211 | -134,165 |
| Change in assets and liabilities: | Noncurrent assets | -10,614 | |
| Change in assets and liabilities: | Accounts payable | -407,972 | 887,560 |
| Change in assets and liabilities: | Accrued liabilities | 1,268,358 | 2,016,556 |
| Change in assets and liabilities: | Current liabilities held for sale | -732,028 | |
| Change in assets and liabilities: | Other current liabilities | 58,246 | |
| Change in assets and liabilities: | Net cash provided by operating activities | 4,497,315 | 3,055,920 |
| Cash flow used in investing activities: | Purchase of property and equipment | -88,848 | -176,928 |
| Cash flow used in investing activities: | Capitalized software | -2,352,959 | -1,449,047 |
| Cash flow used in investing activities: | Purchase of monitoring equipment and parts | -880,851 | -1,448,278 |
| Cash flow used in investing activities: | Proceeds from sale of subsidiary, net of cash included in sale | 748,715 | |
| Cash flow used in investing activities: | Net cash used in investing activities | -3,322,658 | -2,325,538 |
| Cash flow provided by financing activities: | Proceeds from loan payable | 21,000,000 | |
| Cash flow provided by financing activities: | Principal payments on long-term debt | -23,520,000 | -11,399 |
| Cash flow provided by financing activities: | Proceeds from common stock and warrants | 10,312,053 | |
| Cash flow provided by financing activities: | Payment of stock and warrant issuance costs | -2,357,387 | |
| Cash flow provided by financing activities: | Payment of deferred financing fees | -2,303,803 | -52,440 |
| Cash flow provided by financing activities: | Net cash provided by financing activities | 3,130,863 | -63,839 |
| Cash flow provided by financing activities: | Effect of exchange rate changes on cash | -15,045 | -337,439 |
| Cash flow provided by financing activities: | Net increase in cash | 4,290,475 | 329,104 |
| Cash flow provided by financing activities: | Cash and cash held for sale, beginning of period | 4,098,114 | 4,581,625 |
| Cash flow provided by financing activities: | Cash, end of period | 8,388,589 | 4,910,729 |
| Cash flow provided by financing activities: | Cash paid for interest | 221,211 | 48,936 |
| Cash flow provided by financing activities: | Cash paid for taxes | 92,846 | 92,107 |
| Noncash investing activities | Purchase of monitoring equipment in accounts payable | 64,423 | $- |
| Noncash investing activities | Purchase of capitalized software in accounts payable | 101,571 | $- |
| Noncash investing activities | Purchase of property and equipment in accounts payable | 5,571 | $- |
| Noncash financing activities | Issuance costs in accounts payable | 2,262,500 | $- |
| Noncash financing activities | Deferred financing fees in accounts payable | 234,899 | $- |
| Noncash financing activities | Deferred financing fees in exchange for a long-term liability | 750,000 | $- |
| Noncash financing activities | Deferred financing fees in exchange for liability warrants | 755,268 | $- |
Full release
Forward-Looking Statements
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "if", "should" and "will" and similar expressions as they relate to Track Group, Inc., and subsidiaries ("Track Group") are intended to identify such forward-looking statements. These statements are only predictions and reflect Track Group's current beliefs and expectations with respect to future events and are based on assumptions and subject to risks and uncertainties and subject to change at any time. Track Group may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see "Risk Factors" in Track Group's annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. New risks emerge from time to time. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Non-GAAP Financial Measures
This release includes financial measures defined as “non-GAAP financial measures” by the Securities and Exchange Commission including non-GAAP EBITDA. These measures may be different from non- GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with generally accepted accounting principles. Reconciliations of these non-GAAP financial measures are based on the financial figures for the respective period.... (truncated)ins and losses, currency effects, one-time charges or benefits that are not indicative of operations, charges to consolidate, integrate or consider recently acquired businesses, costs of closing facilities, stock based or other non-cash compensation or other stated cash and non-cash charges (the “Adjustments”).
-2-
Non-GAAP Net Debt is defined as total Long-Term Debt before deducting any unamortized issuance costs, plus accrued and unpaid interest, less cash and equivalents.
The Company believes the non-GAAP measures provide useful information to both management and investors when factoring in the Adjustments. Specific disclosure regarding the Company’s financial results, including management’s analysis of results from operations and financial condition, are contained in the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2025, and other reports filed with the Securities and Exchange Commission. Investors are encouraged to carefully read and consider such disclosure and analysis contained in the Company’s Form 10-K and other reports, including the risk factors contained in such Form 10-K.
-3-